Treatment of demyelinating disorders

Details Treatment of demyelinating disorders Treatment of demyelinating disorders

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61K 39/395 (2006.01) A61M 3/00 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2666934

The invention relates to the treatment of demyelinating disorders, e.g. multiple sclerosis, using a soluble lymphotoxin beta receptor (LT.beta.R) as an inhibitor of the lymphotoxin pathway.

L'invention concerne des méthodes de traitement d'un trouble de la démyélinisation à l'aide d'inhibiteurs de la voie de la lymphotoxine.

Affiliated with

Also associated with

Rating

Treatment of demyelinating disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of demyelinating disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of demyelinating disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1537694